Cargando…

Pharmaceutical supply chain risks: a systematic review

INTRODUCTION: Supply of medicine as a strategic product in any health system is a top priority. Pharmaceutical companies, a major player of the drug supply chain, are subject to many risks. These risks disrupt the supply of medicine in many ways such as their quantity and quality and their delivery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaberidoost, Mona, Nikfar, Shekoufeh, Abdollahiasl, Akbar, Dinarvand, Rassoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913399/ https://www.ncbi.nlm.nih.gov/pubmed/24355166 http://dx.doi.org/10.1186/2008-2231-21-69

Ejemplares similares

A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014)

Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods
por: Jaberidoost, Mona, et al.
Publicado: (2015)

A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children
por: Gharibnaseri, Zahra, et al.
Publicado: (2012)

Consistent defined threshold and equity in health
por: Nikfar, Shekoufeh, et al.
Publicado: (2015)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
por: Abdollahias, Akbar, et al.
Publicado: (2011)

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
por: Ahmadiani, Saeed, et al.
Publicado: (2016)

Short and long term impacts of COVID-19 on the pharmaceutical sector
por: Ayati, Nayyereh, et al.
Publicado: (2020)

Pharmaceutical Supply Chain
por: Kuglin, Fred
Publicado: (2015)

“Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector
por: Farshchi, Amir, et al.
Publicado: (2015)

Code of ethics for the national pharmaceutical system: Codifying and compilation
por: Salari, Pooneh, et al.
Publicado: (2013)

Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis
por: Nikfar, Shekoufeh, et al.
Publicado: (2012)

Critical Success Factors and Traceability Technologies for Establishing a Safe Pharmaceutical Supply Chain
por: Haji, Mona, et al.
Publicado: (2021)

Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran
por: Ashrafi Shahmirzadi, Nikinaz, et al.
Publicado: (2021)

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis
por: Zaboli, Pardis, et al.
Publicado: (2017)

Information flow in the pharmaceutical supply chain
por: Yousefi, Nazila, et al.
Publicado: (2015)

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis
por: Rezaie, Ali, et al.
Publicado: (2010)

COVID-19 disruptions and Norwegian food and pharmaceutical supply chains: Insights into supply chain risk management, resilience, and reliability
por: Bø, Eirill, et al.
Publicado: (2023)

Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
por: BenAmor, W. Daoud, et al.
Publicado: (2022)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
por: Goudarzi, Zahra, et al.
Publicado: (2021)

Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran
por: Bastani, Peivand, et al.
Publicado: (2018)

Implementation of the circular supply chain management in the pharmaceutical industry
por: Khan, Feroz, et al.
Publicado: (2022)

Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
por: Delpasand, Mansoor, et al.
Publicado: (2021)

The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
por: Shahtaheri, Rahil Sadat, et al.
Publicado: (2020)

A novel approach for inventory problem in the pharmaceutical supply chain
por: Candan, Gökçe, et al.
Publicado: (2016)

Correction to: Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
por: Delpasand, Mansoor, et al.
Publicado: (2021)

Designing a Transportation-Strategy Decision-Making Process for a Supply Chain: Case of a Pharmaceutical Supply Chain
por: Haial, Afaf, et al.
Publicado: (2021)

Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter
por: Mousavi, Taraneh, et al.
Publicado: (2021)

A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines
por: Zartab, Saman, et al.
Publicado: (2021)

Do companies in the pharmaceutical supply chain earn excess returns?
por: Sood, Neeraj, et al.
Publicado: (2021)

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol
por: Milne-Ives, Madison, et al.
Publicado: (2020)

Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain
por: Rajabzadeh Ghatari, Ali, et al.
Publicado: (2013)

A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2011)

Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste?
por: Alshemari, Abdullah, et al.
Publicado: (2020)

A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer
por: Yazdi, Mohammad Hossein, et al.
Publicado: (2015)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8o87d0124p55k96os084i61eve